Sign in

NCT06661824Completed

Effect of Aggression Management Care Bundle

Effect of Using Care Bundle in the Aggression Management of Patients With Psychotic Disorders

Source: ClinicalTrials.gov · Last updated 14 Jul 2025

Brief summary (registry, in English)

The aim of this sequential randomized controlled experimental design study is to develop an aggression care bundle approach in psychiatric care for patients with psychotic disorders, to use it in a psychiatric clinic, and to evaluate its results. The hypotheses it aims to test are as follows: 1. The aggression management care bundle applied to patients with psychotic disorders in a psychiatric clinic will reduce the risk of developing aggression. 2. The number of aggressive events in the patient group to whom the aggression management care bundle is applied will be less than the control group receiving routine care. 3. The use of restrictive aggression management techniques in the clinic will decrease. 4. The clinical compliance rate of the developed aggression management care bundle will be 95% and above.

Status (registry)
Completed
Study type
Interventional
Enrollment
24 (actual)
First submitted
18 Oct 2024
Start date
30 Jul 2024
Primary completion date
30 Dec 2024
Lead sponsor
Abant Izzet Baysal University
NCT number
NCT06661824

What you commit to

  • Study type: Interventional
  • Participants enrolled: 24
  • From 30 Jul 2024 to the primary completion date, 30 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Being the first time a patient has been admitted to a psychiatric clinic,

Other

  • Not being able to give written informed consent,
  • Having developmental delay or any other significant organic brain pathology.

Who the study is looking for

  • Being between 18-65 years of age,
  • Being able to speak and understand Turkish,
  • Having one of the disorders within the scope of Schizophrenia and psychosis,
  • Being newly admitted to Bolu İzzet Baysal Mental Health and Diseases Hospital during the period the research was conducted,
  • Having scored 1 point or more on the Broset Violence Checklist or 65 points or more on the Buss-Perry Aggression Questionnaire.

Age in the registry: 18 years to 65 years · Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Bolu Mental Health and Diseases Hospital
Coordinator of this site? Confirm its status
BoluTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.